A ferret model of immunosuppression induced with dexamethasone

Vet Immunol Immunopathol. 2022 Jan:243:110362. doi: 10.1016/j.vetimm.2021.110362. Epub 2021 Nov 18.

Abstract

Ferrets are nowadays frequently used as animal models for biomedical purposes; in many cases, immunosuppression of experimental animals is necessary. The aim of this study was to evaluate the effect of intramuscular dexamethasone administration (2 mg/kg as the initiation dose continued with 1 mg/kg q 12 h applied 5 times) on ferret's immune system. In comparison with ferrets which received the saline (n = 5), significantly lower total counts of leukocytes (P < 0.01), lymphocytes (P < 0.01) and monocyte (P < 0.05), as well as absolute numbers of CD4+CD8- (P < 0.01) and CD4-CD8+ (P < 0.01) subsets were noted in dexamethasone treated ferrets (n = 5) the first day after the treatment (D1). Absolute number of CD79+ lymphocytes remained unchanged throughout the experiment. The proliferation activity of lymphocytes in dexamethasone treated ferrets was lower only in D1 using concanavalin A (conA), phytohemagglutinin (PHA) and pokeweed mitogen (PWM); statistical significance was noted using PHA 40 (P < 0.05) and PWM 10 (P < 0.01). Lower neutrophil activity (P < 0.01) was detected in D1 after the dexamethasone treatment in both production of reactive oxygen species (chemiluminescence test) and ingestion of particles (phagocytosis assay). The dexamethasone treatment proved to be useful for short-term immunosuppression in ferrets. The results closely resembled data previously reported in human studies and indicate classification of ferrets as steroid-resistant species.

Keywords: Corticosteroids; Flow cytometry; Immunology; Leukocytes; Mustelidae.

MeSH terms

  • Animals
  • Dexamethasone* / pharmacology
  • Ferrets*
  • Immunosuppression Therapy* / veterinary
  • Lymphocyte Activation
  • Models, Animal
  • Phytohemagglutinins
  • Pokeweed Mitogens

Substances

  • Phytohemagglutinins
  • Pokeweed Mitogens
  • Dexamethasone